Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?

Joyce McKenzie, Alan Jaap, Stephen Gallagher, Ann Rumley, John R Petrie, Gordon D O Lowe, Naveed Sattar

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)682-689
JournalClinical Endocrinology
Publication statusPublished - 2003


  • Hormone Replacement Therapy
  • Cardiovascular risk
  • type 2 diabetes mellitus

Cite this